论文部分内容阅读
研究人员评估了secukinumab(一种人抗白细胞介素17A的单克隆抗体)治疗银屑病关节炎患者的疗效和白细胞介素17A是一种致炎(炎症前)细胞因子,与银屑病关节炎的发病机制密切相连。
Researchers evaluated the efficacy of secukinumab, a human anti-IL-17A monoclonal antibody, in the treatment of patients with psoriatic arthritis and interleukin 17A is a proinflammatory (pre-inflammatory) cytokine that binds to the psoriatic joint The pathogenesis of inflammation is closely linked.